Your Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a…
Success in Rare Disease: Patient Involvement Matters!
This past December, the FDA finalized its guidance on rare diseases with the…
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it…
Happy Anniversary to Us!
I grew up in the Midwest — the middle child in a large family. We were each…
Hybrid Work Strategies: 3 Tips to Transform Engagement
0 Comments8 Minutes
In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation, accelerated innovation, and a…
Medical Affairs: An Orchestra, Not a Horse Race
0 Comments14 Minutes
Every horse race has a starting bell, a push to move as fast as possible, and a finish line. In many ways, the launch of a new drug can feel similar.…
Three Big Mistakes
0 Comments8 Minutes
Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had input into the strategic…
What’s the Latest?
0 Comments9 Minutes
There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of work, that might be what your…
Gen Z Advice for Seasoned Boomers
0 Comments9 Minutes
“Gen Z professionals have a low tolerance for inefficiency and are not going to allow their boomer bosses to remain selective luddites.” That’s how…
Find Your Own Light
0 Comments8 Minutes
It’s no secret that the last few years have been hard on just about everyone. COVID, climate change, political strife in the US and around the world……
The Truth about Teams
0 Comments13 Minutes
When it comes to team performance and adherence to “best practices,” what works on paper or in a teambuilding workshop and what actually occurs are…
Running the Biopharma Marathon
0 Comments7 Minutes
When I moved to Boston over thirty years ago, I had never even heard of the Boston Marathon. I grew up in the Midwest and moved to the West Coast for…
Rare Diseases: Shaping Biopharma’s Future from the Past
0 Comments11 Minutes
We just completed Rare Disease month. With that in mind, Sue has asked me to step in for today’s e-conversation, as this topic is very much a part of…
“Rare Disease” Is More Than Just a Day
0 Comments6 Minutes
You might think it odd for me to begin this month’s e-conversation with a quote from a Supreme Court justice. However, this insight has stuck with me…